UBS Group »

Centessa Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $13k 1.6k 7.96
2023-09-30 $17k 2.6k 6.47
2023-06-30 $13k 2.1k 6.19
2023-03-31 $20k 5.2k 3.85
2022-12-31 $8.0k 2.6k 3.10
2022-09-30 $5.2k 1.6k 3.33
2021-12-31 $6.9k 496 13.89
2021-09-30 $4.0k 221 18.10
2021-06-30 $15k 678 22.12